vs

Side-by-side financial comparison of Community Healthcare Trust Inc (CHCT) and Gevo, Inc. (GEVO). Click either name above to swap in a different company.

Gevo, Inc. is the larger business by last-quarter revenue ($45.3M vs $31.5M, roughly 1.4× Community Healthcare Trust Inc). Community Healthcare Trust Inc runs the higher net margin — 8.1% vs -13.2%, a 21.3% gap on every dollar of revenue. On growth, Gevo, Inc. posted the faster year-over-year revenue change (695.6% vs 4.8%). Over the past eight quarters, Gevo, Inc.'s revenue compounded faster (237.1% CAGR vs 7.0%).

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

Gevo, Inc. is an American renewable chemicals and advanced biofuels company headquartered in unincorporated Douglas County, Colorado, in the Denver-Aurora metropolitan area. Gevo operates in the sustainability sector, pursuing a business model based on the concept of the "circular economy". The company develops bio-based alternatives to petroleum-based products using a combination of biotechnology and classical chemistry. Gevo uses the GREET model from Argonne National Laboratory as a basis f...

CHCT vs GEVO — Head-to-Head

Bigger by revenue
GEVO
GEVO
1.4× larger
GEVO
$45.3M
$31.5M
CHCT
Growing faster (revenue YoY)
GEVO
GEVO
+690.8% gap
GEVO
695.6%
4.8%
CHCT
Higher net margin
CHCT
CHCT
21.3% more per $
CHCT
8.1%
-13.2%
GEVO
Faster 2-yr revenue CAGR
GEVO
GEVO
Annualised
GEVO
237.1%
7.0%
CHCT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CHCT
CHCT
GEVO
GEVO
Revenue
$31.5M
$45.3M
Net Profit
$2.5M
$-6.0M
Gross Margin
Operating Margin
-4.8%
Net Margin
8.1%
-13.2%
Revenue YoY
4.8%
695.6%
Net Profit YoY
60.2%
65.9%
EPS (diluted)
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHCT
CHCT
GEVO
GEVO
Q1 26
$31.5M
Q4 25
$30.9M
$45.3M
Q3 25
$31.1M
$42.7M
Q2 25
$29.1M
$43.4M
Q1 25
$30.1M
$29.1M
Q4 24
$29.3M
$5.7M
Q3 24
$29.6M
$2.0M
Q2 24
$27.5M
$5.3M
Net Profit
CHCT
CHCT
GEVO
GEVO
Q1 26
$2.5M
Q4 25
$14.4M
$-6.0M
Q3 25
$1.6M
$-8.0M
Q2 25
$-12.6M
$2.1M
Q1 25
$1.6M
$-21.7M
Q4 24
$1.8M
$-17.6M
Q3 24
$1.7M
$-21.2M
Q2 24
$-10.4M
$-21.0M
Operating Margin
CHCT
CHCT
GEVO
GEVO
Q1 26
Q4 25
-4.8%
Q3 25
-8.6%
Q2 25
13.4%
Q1 25
-69.2%
Q4 24
-344.7%
Q3 24
-1221.8%
Q2 24
-456.8%
Net Margin
CHCT
CHCT
GEVO
GEVO
Q1 26
8.1%
Q4 25
46.6%
-13.2%
Q3 25
5.3%
-18.6%
Q2 25
-43.2%
4.9%
Q1 25
5.3%
-74.6%
Q4 24
6.3%
-308.9%
Q3 24
5.9%
-1076.6%
Q2 24
-37.9%
-399.3%
EPS (diluted)
CHCT
CHCT
GEVO
GEVO
Q1 26
Q4 25
$0.52
$-0.03
Q3 25
$0.03
$-0.03
Q2 25
$-0.50
$0.01
Q1 25
$0.03
$-0.09
Q4 24
$0.04
$-0.08
Q3 24
$0.04
$-0.09
Q2 24
$-0.42
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHCT
CHCT
GEVO
GEVO
Cash + ST InvestmentsLiquidity on hand
$2.6M
$81.2M
Total DebtLower is stronger
$164.8M
Stockholders' EquityBook value
$421.3M
$466.3M
Total Assets
$1.0B
$718.9M
Debt / EquityLower = less leverage
0.35×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHCT
CHCT
GEVO
GEVO
Q1 26
$2.6M
Q4 25
$3.3M
$81.2M
Q3 25
$3.4M
$72.6M
Q2 25
$4.9M
$57.3M
Q1 25
$2.3M
$65.3M
Q4 24
$4.4M
$189.4M
Q3 24
$2.8M
$223.2M
Q2 24
$734.0K
$245.7M
Total Debt
CHCT
CHCT
GEVO
GEVO
Q1 26
Q4 25
$532.2M
$164.8M
Q3 25
$530.1M
$164.5M
Q2 25
$500.1M
$167.5M
Q1 25
$496.0M
$167.0M
Q4 24
$486.0M
$67.1M
Q3 24
$473.7M
$67.0M
Q2 24
$457.6M
$66.8M
Stockholders' Equity
CHCT
CHCT
GEVO
GEVO
Q1 26
$421.3M
Q4 25
$429.4M
$466.3M
Q3 25
$426.8M
$468.9M
Q2 25
$437.8M
$474.1M
Q1 25
$461.3M
$469.8M
Q4 24
$476.0M
$489.5M
Q3 24
$477.2M
$504.7M
Q2 24
$497.8M
$522.7M
Total Assets
CHCT
CHCT
GEVO
GEVO
Q1 26
$1.0B
Q4 25
$990.8M
$718.9M
Q3 25
$987.3M
$685.2M
Q2 25
$966.3M
$702.1M
Q1 25
$985.1M
$677.8M
Q4 24
$992.6M
$583.9M
Q3 24
$981.8M
$583.9M
Q2 24
$983.2M
$617.9M
Debt / Equity
CHCT
CHCT
GEVO
GEVO
Q1 26
Q4 25
1.24×
0.35×
Q3 25
1.24×
0.35×
Q2 25
1.14×
0.35×
Q1 25
1.08×
0.36×
Q4 24
1.02×
0.14×
Q3 24
0.99×
0.13×
Q2 24
0.92×
0.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHCT
CHCT
GEVO
GEVO
Operating Cash FlowLast quarter
$20.0M
Free Cash FlowOCF − Capex
$8.7M
FCF MarginFCF / Revenue
19.3%
Capex IntensityCapex / Revenue
24.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-43.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHCT
CHCT
GEVO
GEVO
Q1 26
Q4 25
$56.4M
$20.0M
Q3 25
$12.7M
$-6.8M
Q2 25
$13.8M
$-2.5M
Q1 25
$14.4M
$-24.0M
Q4 24
$58.9M
$-18.8M
Q3 24
$13.8M
$-11.0M
Q2 24
$16.7M
$-11.4M
Free Cash Flow
CHCT
CHCT
GEVO
GEVO
Q1 26
Q4 25
$35.9M
$8.7M
Q3 25
$7.6M
$-14.6M
Q2 25
$9.6M
$-7.8M
Q1 25
$9.7M
$-29.9M
Q4 24
$34.2M
$-33.5M
Q3 24
$6.7M
$-20.8M
Q2 24
$9.5M
$-20.6M
FCF Margin
CHCT
CHCT
GEVO
GEVO
Q1 26
Q4 25
116.0%
19.3%
Q3 25
24.6%
-34.2%
Q2 25
32.9%
-17.9%
Q1 25
32.3%
-102.7%
Q4 24
116.9%
-587.2%
Q3 24
22.5%
-1057.0%
Q2 24
34.7%
-392.4%
Capex Intensity
CHCT
CHCT
GEVO
GEVO
Q1 26
Q4 25
66.3%
24.7%
Q3 25
16.3%
18.3%
Q2 25
14.5%
12.1%
Q1 25
15.6%
20.0%
Q4 24
84.1%
256.6%
Q3 24
24.2%
496.2%
Q2 24
26.1%
174.8%
Cash Conversion
CHCT
CHCT
GEVO
GEVO
Q1 26
Q4 25
3.91×
Q3 25
7.76×
Q2 25
-1.18×
Q1 25
9.06×
Q4 24
32.14×
Q3 24
7.92×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons